Digest Network Come funziona
Network
/
Società
No
Non verificato

Novo Nordisk A/S

Di cosa scriviamo

FarmaceuticaFinanzaManagement/Organizzazione AziendalePolitica InternazionalePubblicità/Marketing/Media/Comunicazione

63 comunicati stampa

Guarda tutti i comunicati
12/12/2025
Farmaceutica
Pubblicità/Marketing/Media/Comunicazione
Novo Nordisk A/S: More efficacious dose of Wegovy® recommended by the European Medicines Agency can help people with obesity achieve an average of 20.7% weight loss
Fonte
Novo Nordisk A/S
Emittente
GLOBENEWSWIRE
1.00
0
09/12/2025
Farmaceutica
Pubblicità/Marketing/Media/Comunicazione
Novo Nordisk has completed its acquisition of Akero Therapeutics
Fonte
Novo Nordisk A/S
Emittente
GLOBENEWSWIRE
1.00
0
25/11/2025
Farmaceutica
Politica Internazionale
Novo Nordisk phase 2 trial with amycretin reports significant weight loss and HbA1c reduction in type 2 diabetes
Fonte
Novo Nordisk A/S
Emittente
GLOBENEWSWIRE
1.00
0
24/11/2025
Farmaceutica
Politica Internazionale
Novo Nordisk A/S: Evoke phase 3 trials did not demonstrate a statistically significant reduction in Alzheimer's disease progression
Fonte
Novo Nordisk A/S
Emittente
GLOBENEWSWIRE
1.00
0
14/11/2025
Farmaceutica
Politica Internazionale
Resolutions from the Extraordinary General Meeting of Novo Nordisk A/S
Fonte
Novo Nordisk A/S
Emittente
GLOBENEWSWIRE
1.00
0
13/11/2025
Farmaceutica
Politica Internazionale
Novo Nordisk A/S: Candidate for the Board of Directors will not seek election
Fonte
Novo Nordisk A/S
Emittente
GLOBENEWSWIRE
1.00
0
06/11/2025
Farmaceutica
Politica Internazionale
Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost
Fonte
Novo Nordisk A/S
Emittente
GLOBENEWSWIRE
1.00
0
05/11/2025
Farmaceutica
Medicina Salute Benessere
Novo Nordisk Wegovy® users achieved waist and BMI targets linked to improved health and low risk of obesity-related complications
Fonte
Novo Nordisk A/S
Emittente
GLOBENEWSWIRE
1.00
0
04/11/2025
Farmaceutica
Management/Organizzazione Aziendale
Annunci Economici
Politica Internazionale
Novo Nordisk's sales increased by 12% in Danish kroner and by 15% at CER in the first nine months of 2025; R&D pipeline progress continues
Fonte
Novo Nordisk A/S
Emittente
GLOBENEWSWIRE
1.00
0
30/10/2025
Farmaceutica
Politica Internazionale
Novo Nordisk submits proposal to acquire Metsera, Inc.
Fonte
Novo Nordisk A/S
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0